What is Daridorexant Hydrochloride?
Daridorexant hydrochloride is a medication approved for treating insomnia in adults [1]. It works by blocking the activity of orexins, which are neuropeptides that promote wakefulness. By inhibiting orexin signaling, daridorexant hydrochloride helps to reduce sleep-wake drive, leading to improved sleep [1].
How Does Daridorexant Hydrochloride Work?
Daridorexant hydrochloride functions as a dual orexin receptor antagonist. It binds to both OX1R and OX2R receptors in the brain, preventing the binding of orexin-A and orexin-B, the natural ligands for these receptors [1][2]. This antagonism suppresses the wake-promoting signals, allowing for the onset and maintenance of sleep [1]. Unlike some other insomnia medications that sedate the central nervous system, daridorexant hydrochloride targets the wakefulness pathway directly [2].
When Will Daridorexant Hydrochloride Patents Expire?
Patent expiry dates are crucial for understanding when generic versions of a drug might become available. While specific patent expiry timelines can be complex and subject to challenges, information on the patent landscape for daridorexant hydrochloride can be found through resources like DrugPatentWatch.com [3]. These resources track active patents, their expiry dates, and any potential legal disputes that could affect market exclusivity.
Who Makes Daridorexant Hydrochloride?
Daridorexant hydrochloride is manufactured by Idorsia Pharmaceuticals [1]. It is marketed under the brand name Quviviq [1].
What Are the Side Effects of Daridorexant Hydrochloride?
Common side effects associated with daridorexant hydrochloride include somnolence, headache, and fatigue [1]. Patients are advised to report any persistent or bothersome side effects to their healthcare provider [1].
How Does Daridorexant Hydrochloride Compare to Other Sleep Medications?
Daridorexant hydrochloride's mechanism of action, targeting the orexin system, distinguishes it from other classes of sleep medications like benzodiazepines or non-benzodiazepine hypnotics, which act as GABA receptor modulators [2]. This difference may lead to a different side effect profile and potentially a reduced risk of dependence or withdrawal symptoms associated with longer-term use.
What Are the Clinical Trial Results for Daridorexant Hydrochloride?
Clinical trials for daridorexant hydrochloride have demonstrated its efficacy in improving sleep onset and sleep maintenance in adults with insomnia [1]. Studies have shown statistically significant improvements in objective measures of sleep, such as latency to persistent sleep and total sleep time, as well as subjective patient-reported outcomes [1].
What Are the Risks Associated with Daridorexant Hydrochloride?
Potential risks associated with daridorexant hydrochloride include complex sleep behaviors, such as sleepwalking or sleep-driving, which can occur with or without awareness [1]. Due to this risk, patients with a history of such behaviors should not take the medication [1]. It is also important for patients to be aware of the potential for somnolence and its impact on daily activities, including driving [1].
Can Daridorexant Hydrochloride Be Used Long-Term?
The long-term safety and efficacy of daridorexant hydrochloride are evaluated through ongoing clinical studies. Patients should use the medication as prescribed by their healthcare provider and discuss any concerns about long-term use [1].
---
1. https://www.fda.gov/drugs/drug-approvals/quviviq-daridorexant-approved-treat-insomnia
2. https://www.drugpatentwatch.com/drug/daridorexant-hydrochloride
3. https://www.drugpatentwatch.com/